Eugen Mengel Selected Research

Pain (Aches)

2/2017	Impact of elosulfase alfa in patients with morquio A syndrome who have limited ambulation: An open-label, phase 2 study.
11/2012	Clinical characteristics of adults with slowly progressing mucopolysaccharidosis VI: a case series.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eugen Mengel Research Topics

Disease

15	Gaucher Disease (Gaucher's Disease) 01/2020 - 02/2004
11	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 11/2021 - 09/2009
10	Disease Progression 03/2022 - 02/2004
10	Glycogen Storage Disease Type II (Pompe's Disease) 02/2020 - 02/2010
5	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2020 - 03/2007
4	Splenomegaly 01/2022 - 10/2006
4	Fabry Disease (Fabry's Disease) 01/2020 - 09/2006
4	Mucopolysaccharidoses 02/2015 - 11/2013
3	Neurologic Manifestations (Neurological Manifestations) 01/2020 - 10/2011
3	Body Weight (Weight, Body) 09/2015 - 10/2011
3	Hepatomegaly 10/2010 - 10/2006
2	Sphingolipidoses (Sphingolipidosis) 03/2022 - 01/2014
2	Niemann-Pick Diseases (Niemann Pick Disease) 01/2022 - 01/2019
2	Pain (Aches) 02/2017 - 11/2012
2	Mucopolysaccharidosis VI (Syndrome, Maroteaux-Lamy) 03/2014 - 11/2013
2	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 06/2012 - 04/2008
2	Spontaneous Abortion (Miscarriage) 05/2011 - 11/2009
1	Gangliosidoses (Gangliosidosis) 03/2022
1	Gliosis 03/2022
1	GM1 Gangliosidosis (Gangliosidosis GM1) 03/2022
1	GM2 Gangliosidoses (GM2 Gangliosidosis) 03/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2020
1	Muscular Diseases (Myopathy) 02/2020
1	Mucopolysaccharidosis III (Sanfilippo Syndrome) 01/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2020
1	Respiratory Insufficiency (Respiratory Failure) 01/2017
1	Airway Obstruction (Choking) 01/2017
1	Epilepsy (Aura) 01/2016
1	Spinal Cord Diseases 01/2016
1	Intellectual Disability (Idiocy) 01/2016
1	Muscle Hypotonia (Hypotonia) 01/2016
1	Brain Diseases (Brain Disorder) 01/2016
1	Mental Disorders (Mental Disorder) 01/2016
1	Mucopolysaccharidosis IV (Morquio Syndrome) 01/2016
1	Ataxia (Dyssynergia) 01/2016
1	Methylenetetrahydrofolate reductase deficiency 01/2016
1	Microcephaly 01/2016
1	Hydrocephalus (Hydrocephaly) 01/2016
1	Cerebellar Ataxia (Dysmetria) 10/2015
1	Fibrosis (Cirrhosis) 09/2015
1	Wolman Disease (Wolman's Disease) 09/2015
1	Dyslipidemias (Dyslipidemia) 09/2015
1	Failure to Thrive 01/2015
1	Pneumonia (Pneumonitis) 01/2015
1	Hypersensitivity (Allergy) 01/2015
1	Congenital Abnormalities (Deformity) 01/2015
1	Cardiomegaly (Heart Hypertrophy) 01/2015
1	Gastroesophageal Reflux (GERD) 01/2015
1	Hearing Loss (Hearing Impairment) 01/2015
1	Hydrops Fetalis (Fetal Edema) 11/2012
1	Ascites 11/2012
1	Edema (Dropsy) 11/2012
1	Flatulence 10/2011
1	Abdominal Pain (Pain, Abdominal) 10/2011

Drug/Important Bio-Agent (IBA)

10	EnzymesIBA 01/2020 - 04/2008
7	Biomarkers (Surrogate Marker)IBA 03/2022 - 05/2008
7	LipidsIBA 11/2020 - 05/2008
6	AcidsIBA 01/2019 - 02/2010
4	miglustat (Zavesca)FDA Link 01/2020 - 10/2011
4	Glucosylceramidase (Glucocerebrosidase)IBA 11/2017 - 02/2004
4	imiglucerase FDA Link 12/2014 - 11/2009
3	GlucosidasesIBA 02/2020 - 05/2011
3	Lysergic Acid Diethylamide (LSD)IBA 01/2020 - 10/2010
3	CholesterolIBA 07/2019 - 09/2009
3	alpha-Glucosidases (Acid Maltase)IBA 01/2017 - 02/2010
3	Glucosylceramides (Glucocerebrosides)IBA 05/2008 - 02/2004
2	SphingolipidsIBA 03/2022 - 01/2014
2	human GAA protein (Myozyme)FDA Link 01/2017 - 09/2012
2	Amino Acids FDA Link 10/2015 - 06/2011
2	human GALNS proteinIBA 02/2015 - 11/2014
2	alpha-Galactosidase (Beano)IBA 04/2008 - 09/2006
1	Pharmaceutical PreparationsIBA 03/2022
1	Proteins (Proteins, Gene)FDA Link 03/2022
1	Glial Fibrillary Acidic ProteinIBA 03/2022
1	olipudase alfaIBA 01/2022
1	Carbon MonoxideIBA 01/2022
1	arimoclomolIBA 11/2021
1	Waste Products (Waste Product)IBA 01/2020
1	Sulfates (Sulfates, Inorganic)IBA 07/2019
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 01/2019
1	Keratan SulfateIBA 02/2017
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2016
1	HomocysteineIBA 01/2016
1	Methionine (L-Methionine)FDA Link 01/2016
1	acetylleucineIBA 10/2015
1	Sebelipase alfaIBA 09/2015
1	LDL CholesterolIBA 09/2015
1	taliglucerase alfaIBA 12/2014
1	sphingosine phosphorylcholineIBA 01/2014
1	CreatinineIBA 11/2012
1	Lactose FDA LinkGeneric 10/2011
1	CarbohydratesIBA 10/2011
1	Dietary Sucrose (Table Sugar)IBA 10/2011

Therapy/Procedure

23	Enzyme Replacement Therapy 01/2022 - 03/2007
11	Therapeutics 03/2022 - 10/2011
2	Anesthesia 01/2016 - 01/2015
2	Decompression 11/2013 - 11/2012
2	Enzyme Therapy 11/2009 - 02/2004
1	Tracheostomy 01/2017
1	Diet Therapy (Therapy, Diet) 10/2011